Professional Documents
Culture Documents
Received: December 2010 Shahid Beheshti University of Medical Sciences and Health Services
Accepted: February 2011
Original Article
Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing,100850, China.
Abstract
* Corresponding author:
E-mail addresses: qdqwzb@163.com
Dongqin Q et al. / IJPR (2012), 11 (1): 257-264
seizure control due to the formation of CBZ as well as reducing the intra- and inter subject
dihydrate (9, 10). variability of the blood level of CBZ in-vivo.
Self-microemulsifying drug delivery system
(SMEDDS) can be defined as an isotropic multi- Experimental
component drug delivery system composed of
Materials and apparatus
surfactant, co-surfactant and oil, which
spontaneously form microemulsion in the API of CBZ was purchased from Jiuzhou
presence of water (11-12). Conventional self- pharmaceutical Industrial Co.(China), Tween 80
microemulsifying drug delivery systems and PEG400 were obtained from sigma Chem.
(SMEDDS) are widely used in enhancing the oral Co. and medium chain triglycerides (MIGLYOL
absorption of poorly-soluble drugs (13-16). When 812N) were supplied by Gatte-fosse (France);
SMEDDS formulations introduced into Cremphor EL-35 was from BASF (Germany), and
gastrointestinal area (GI), drug precipitation may PVPK30 was from ISP (USA). S-SMEDDS of
be occurred and lead to failure of improvement of CBZ were prepared by our lab and CBZ tablets
intestinal absorption. On the other hand, high were purchased from Shanghai Sanlian Pharma
surfactant level typically present in SMEDDS Ltd. (batch No.20061101). Beagle dogs were from
formulations can cause GI side-effects. The animal center of Academy of Military Medical
supersaturatable self-microemulsifying drug Sciences 13-15 Kg male.
delivery system (S-SMEDDS) represents a new Hermle Z200A high speed centrifugator was
thermodynamically stable formulation approach from Germany, Hitachi L-7100, HPLC was
wherein it is designed to contain a reduced from Japan, QL-901 vortex mixer came from
amount of surfactant and a water-soluble polymer Shanghai, China UV-160A vis-ultraviolet
(precipitation inhibitor or supersaturated spectrophotometer was from SHIMAZU Co.
promoter) to prevent precipitation of the drug by Tokyo, Japan, and ELECTROLAB TDT-08L
generating and maintaining a supersaturated state drug dissolution test instrument was made in
in-vivo. The S-SMEDDS formulations can result ELECTROLAB corporation, U.S.A.
in enhanced oral absorption as compared with the
related self-emulsifying drug delivery systems Different formulations of CBZ
(SMEDDS) formulation and the reduced Three formulations with or without
surfactant levels may minimize gastrointestinal precipitation inhibitor were prepared as showed in
surfactant side effects (17-20). Table 1. Formulation A (SMEDDS) with high
In S-SMEDDS, solubilization of CBZ in o/w level of surfactant without precipitation inhibitor,
microemulsions will enhance its bioavailability with Formulation B (S-SMEDDS) with low level of
low surfactant level and CBZ can be absorbed in GI surfactant with 2% (w/w) precipitation inhibitor
homogeneously, which may reduce variability in and Formulation C (SMEDDS) with low level of
plasma concentration. The main objectives of the surfactant without precipitation inhibitor were
study were to develop S-SMEDDS of CBZ to compared and evaluated.
improve its dissolution in-vitro and bioavailability
inhibitor
Formulation A 37 15 45 0
Formulation B 40 20 35 2
Formulation C 40 22 35 0
258
Evaluation of Carbamazepine (CBZ) Supersaturatable Self-Microemulsifying (S-SMEDDS) Formulation In-vitro and In-vivo
259
Dongqin Q et al. / IJPR (2012), 11 (1): 257-264
by HPLC. The washout period was one week. solubilized for a prolonged period of time(over 24
h) when PVPK90 was added as precipitate
Table 2. Drug administration to beagle dogs inhibitor in the formulation at low surfactant
Administration period Animal number level, while drug precipitation occurred within 4 h
1 2 3 4 5 6 when formulating without precipitate inhibitor. S-
1 A B A B A B SMEDDS may generate a protracted
2 B A B A B A supersaturated solution of the drug with a reduced
surfactant level when the formulation is released
into an aqueous medium.
Determination of CBZ concentration in plasma
Table 3. The content(w/w, %) of CBZ S-SMEDDS after dilution.
The mobile phase consisted of methanol-water
(57:43, v/v), at a flow rate of 1 mL/min. The column Formulations Time (h)
0 4 8 12 24 36 72
used was ZORBAX SB-C18 (4.6 mm×150 mm, 5
μm).The detection wavelength was 285 nm. 50 µL of Formulation A 100 99.9 99.7 80.5 68.3 — —
Formulation B 100 99.9 99.7 100.3 99.8 75.5 54.3
diazepam(10.0 μg/mL) internal standard solution
was added to 0.5 mL plasma in a 10 mL glass Formulation C 100 70.2 48.7 — — — —
centrifuge tube for assay and then 3 mL ethylether
was added, the samples were shaken for 5 min by
vortex mixer and centrifuged at 3000 r/min for 10 Dissolution test in-vitro
min. The supernatant phase was separated and Dissolution curve Figure 1 showed that over
evaporated to dryness at 40°C under nitrogen. 90% of CBZ dissolved from the self-emulsifying
Residues were dissolved in 100 µL mobile phase and formulations within 20 min, behaving like a fast-
were assayed by HPLC. dissolving immediate release drug product, and
from the commercial tablets, only 30% of the dose
Data analysis was released within 20 min. The self-emulsifying
Pharmacokinetic analysis was performed by systems can significantly increase CBZ
means of a model independent method using dissolution rate in-vitro.
DAS2.0 computer program (issued by the State
Food and Drug Administration of China for
pharmacokinetic study). The area under the plasma Caco-2 cell permeability study
concentration versus time curve from zero to 12 h The three S-SMEDDS formulations were
(AUC0~12h) was calculated by linear trapezoidal rule presumed to enhance CBZ transport across the cell
from zero to the last plasma concentration. The membrane. Increased drug absorption through the
maximum plasma concentration, Cmax, and the time intestinal mucosa is often associated with damage
of its occurrence, Tmax, were compiled from the caused to the intestinal cells and to their barrier
concentration–time data. All results were expressed function. The effect of different CBZ formulations
as mean ± SD. The data from different formulations on the monolayer integrity was examined by
were compared for statistical significance by one measuring the TEER-value before and after
way analysis of variance (ANOVA). T-tests were treatment of CaCO-2 cell monolayers with three
performed to evaluate the significant differences formulations (formulation A, B, C of Table 1) for
between the two formulations and the data were predetermined time intervals of 15, 30, 45 and 60
considered statistically significant at p < 0.05. min. As demonstrated in Figure 2, the results
showed a reduction in TEER-values after the
experiment. This implied that S-SMEDDS may
Results and Discussion affect the paracellular route through the opening of
tight junctions and thus reduce the cell integrity of
In-vitro evaluation of precipitation Caco-2 cells. However, TEER-values measured 48 h
Based on the results of Table 3, the drug after transport experiment (recovery) revealed that
precipitation can be prevented and CBZ kept all the monolayers fully recovered (TEER-values
260
Evaluation of Carbamazepine (CBZ) Supersaturatable Self-Microemulsifying (S-SMEDDS) Formulation In-vitro and In-vivo
were higher than 600 Ω•cm 2). This indicated that and 60 min( Figure 3), it can be observed that
although the formulations affected the tightness of they were not statistically different when treated
the cell monolayer, it reversibly recovered after the with formulation A and formulation B (p > 0.05),
experiment. On the other hand, the TEER-value of but had significant differences between
monolayers reduced remarkably when treated with formulation B and formulation C (p < 0.05). With
formulation A (high surfactant concentration, p < the same drug permeability, formulation B (with
0.05), and there was no significant differences precipitation inhibitor (S-SMEDDS)) decreased
between formulation B and formulation C (p > 0.05). impairment to cells due to a lower surfactant level
From the results of permeability of CBZ across compared to formulation A (SMEDDS) with high
CaCO-2 cell mono-layers for 15, 30, 45 surfactant concentration.
261
Dongqin Q et al. / IJPR (2012), 11 (1): 257-264
262
Evaluation of Carbamazepine (CBZ) Supersaturatable Self-Microemulsifying (S-SMEDDS) Formulation In-vitro and In-vivo
263
Dongqin Q et al. / IJPR (2012), 11 (1): 257-264
References 619-630.
(12) Sangkil LEE, Jaehwi LEE and Young Wook CHOI.
(1) Kelmann RG and Kuminek G. Carbamazepine Design and evaluation of prostaglandin e1 (pge1)
parenteral nanoemulsions prepared by spontaneous intraurethral liquid formulation employing Self-
emulsification process. Int. J. Pharm. (2007) 342: Microemulsifying Drug Delivery System (SMEDDS)
231-239. for erectile dysfunction treatment. Biol. Pharm. Bull.
(2) Carino SR, Sperry DC and Hawley M. Relative (2008) 31: 668-672.
bioavailability estimation of carbamazepine crystal (13) Barzegar-Jalali M, Valizadeh H, Dastmalchi S, Siahi
forms using an artificial stomach-duodenum model. J. Shadbad MR, Barzegar-Jalali A, Adibkia KH and
Pharm. Sci. (2006) 95: 116-125. Mohammadi GH. Enhancing dissolution rate of
(3) A Nokhodchi N, Maghsoodi M and Hassanzadeh D. An carbamazepine via cogrinding with crospovidone and
Improvement of physicomechanical properties of hydroxypropylmethylcellulose. Iranian J. Pharm.
carbamazepine crystals. Iranian J. Pharm. Res. (2007) Res. (2007) 6:159-165.
6: 83-93. (14) Patel AR and Vavia PR. Preparation and in-vivo
(4) Dong WY, Maincent P and Bodmeier R. In-vitro and evaluation of SMEDDS (Self-Microemulsifying Drug
in-vivo evaluation of carbamazepine-loaded enteric Delivery System) containing fenofibrate. AAPS J.
microparticles. Int. J. Pharm. (2007) 331: 84-92. (2007) 9: E344-E352.
(5) Barzegar-Jalali M, Nayebi AM, Valizadeh H. (15) Kreilgaard M, Pedersen EJ and Jaroszewski JW.
Evaluation of in-vitro, in-vivo correlation and NMR characterization and transdermal drug delivery
anticonvulsive effect of carbamazepine after potential of microemulsion systems. J. Control. Rel.
cogrinding with microcrystalline cellulose. J. Pharm. (2000) 69: 421-433.
Sci. (2006) 9: 307-316. (16) Feng-Feng LV, Li-Qiang Zheng and Chen-Ho Tung
(6) Sethia S and Squillante E. Solid dispersion of initial. Phase behavior of the microemulsions and the
carbamazepine in PVP K30 by conventional solvent stability of the chloramphenicol in the
evaporation and supercritical methods. Int. J. Pharm. microemulsion-based ocular drug delivery system.
(2004) 272: 1-10. Int. J. Pharm. (2005) 301: 237–246.
(7) Barakat NS and Radwan MA. In-vitro performance of (17) Gao P and Morozowich W. Development of
carbamazepine loaded to various molecular weights of supersaturatable self-emulsifying drug delivery
poly (D, L-lactide-co-glycolide). Drug Deliv. (2006) system formulations for improving the oral absorption
13: 9-18. of poorly-soluble drugs. Expert Opin. Drug Deliv.
(8) Müller RH, Schmidt S and Buttle I, et al??? (2006) 3: 97-110.
SolEmuls-novel technology for the formulation of i.v. (18) Gao P, Guyton ME, Huang T. Enhanced oral
emulsions with poorly-soluble drugs. Int. J. Pharm. bioavailability of a poorly water-soluble drug PNU-
(2004) 269: 293-302. 91325 by supersaturatable formulations. Drug Devel.
(9) Neslihan, Gursoy R and Benita S. Self-emulsifying Ind. Pharm. (2004) 30: 221-229.
drug delivery systems (SEDDS) for improved oral (19) Gao P, Rush RD, Pfund WP. Development of a
delivery of lipophilic drugs (J). Biomed. supersaturatable SEDDS (S-SEDDS) formulation of
Pharmacother. (2004) 58: 173-182. paclitaxel with improved oral bioavailability. J.
(10) Subramanian N., Ray S., Ghosal SK. Formulation Pharm. Sci. (2003) 92: 2395-2407.
design of self-microemulsifying drug delivery (20) Gao P, Anna A and Chandra M. Characterization and
systems for improved oral bioavailability of optimization of AMG 517 supersaturatable self-
celecoxib. Biol. Pharm. Bull. (2004) 27: 1993-1999. emulsifying drug delivery system (S-SEDDS) for
(11) Borhade VB, Nair HA and Hegde DD. Development improved oral absorption. J. Pharm. Sci. (2009) 98:
and characterization of self-microemulsifying drug 516-528.
delivery system of tacrolimus for intravenous
This article is available online at http://www.ijpr.ir
administration. Drug Dev. Ind. Pharm. (2009) 35:
264